EUVIMEDEUVIMED entdecken
Crossref

Clinical factors influencing asthma direct cost in children and adolescents with mild to moderate asthma.

Dardouri, Maha, Jihène Bouguila, Jihene Sahli, Chekib Zedini, Manel Mallouli, Mtiraoui, Ali

Biomedicine & Healthcare Research (BHR) · 02.03.2023

DOI: 10.71599/bhr.v1i1.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedicine & Healthcare Research (BHR), erschienen am 02.03.2023. Verfasst von Dardouri und 7 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Asthma imposes a substantial economic burden on the health care system and community worldwide. Annual direct asthma cost and the factors that influence this cost are not yet addressed in Tunisia, particularly in the pediatric population. This study aimed to identify clinical factors determining the annual direct cost of pediatric asthma. The current study was cross-sectional, carried out in Farhat Hached University Hospital in Sousse, Tunisia, over three months among children with asthma aged 7-17 years. Asthma direct cost was defined as the cost of healthcare resources utilization and medication related to asthma in the past 12 months. Multiple regression was performed to examine the association between total asthma direct cost and clinical factors. Ninety children with mild to moderate asthma were included in the study. The findings showed that 67.8% were 7-11 years and 55.6% were boys. The annual mean of total direct asthma cost was $616.71±454. Multiple regression showed that severity of asthma (B1= 402.473, 95% CI 163.414 to 641.532, p=0.001), medication adherence (B2= -265.656, 95% CI -434.194 to -97.118, p=0.002), and quality of life of children (B3= -103.257, 95% CI -173.687 to -32.828, p=0.005) were significantly associated with asthma direct cost. In conclusion, this study underlined the substantial economic burden of mild to moderate asthma in Tunisian children and adolescents. Asthma direct cost increased with asthma severity stage, suboptimal medication adherence, and impaired quality of life. Asthma management action plans are needed to limit asthma direct cost.

Schlagwörter

childhood asthmaeconomic burden of asthmaasthma severitymedication adherencequality of lifehealthcare resource utilizationchildren and adolescentsTunisia

Zitieren

APA

Dardouri, Maha, Bouguila, J., Sahli, J., Zedini, C., Mallouli, M., Mtiraoui, & Ali (2023). Clinical factors influencing asthma direct cost in children and adolescents with mild to moderate asthma. Biomedicine & Healthcare Research (BHR). https://doi.org/10.71599/bhr.v1i1.7

Vancouver

Dardouri, Maha, Bouguila J, Sahli J, Zedini C, Mallouli M, et al. Clinical factors influencing asthma direct cost in children and adolescents with mild to moderate asthma. Biomedicine & Healthcare Research (BHR). 2023. doi:10.71599/bhr.v1i1.7

BibTeX
@article{Dardouri2023,
  author = {Dardouri and Maha and Bouguila, Jihène and Sahli, Jihene and Zedini, Chekib and Mallouli, Manel and Mtiraoui and Ali},
  title = {Clinical factors influencing asthma direct cost in children and adolescents with mild to moderate asthma},
  journal = {Biomedicine & Healthcare Research (BHR)},
  year = {2023},
  doi = {10.71599/bhr.v1i1.7}
}
Kostenlos starten →